Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Incyte Corporation(INCY) | 30,762,330 | 30,762,652 | +322 | $3.49B | $3.73B | 17.74% | +$245.83M |
| BeOne Medicines AGADS(ONC) | 8,801,567 | 8,832,335 | +30,768 | $2.51B | $3.23B | 15.36% | +$723.92M |
| Revolution Medicines, Inc.(RVMD) | 11,443,357 | 10,637,318 | -806,039 | $2.14B | $2.18B | 10.38% | +$40.30M |
| Kodiak Sciences Inc.(KOD) | 19,919,186 | 21,860,941 | +1,941,755 | $776.05M | $2.07B | 9.85% | +$1.30B |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 2,143,131 | 2,143,131 | 0 | $1.15B | $1.08B | 5.13% | -$70.70M |
| Insmed Incorporated(INSM) | 8,796,111 | 8,796,111 | 0 | $937.84M | $1.00B | 4.77% | +$66.15M |
| Kymera Therapeutics, Inc.(KYMR) | 8,657,242 | 8,657,242 | 0 | $992.73M | $967.79M | 4.60% | -$24.93M |
| ACADIA Pharmaceuticals Inc. | 42,912,904 | 42,912,904 | 0 | $1.09B | $864.70M | 4.11% | -$221.00M |
| GRAIL, Inc.(GRAL) | 4,028,614 | 4,028,614 | 0 | $275.03M | $564.49M | 2.68% | +$289.46M |
| Summit Therapeutics Inc.(SMMT) | 32,786,348 | 32,786,348 | 0 | $477.70M | $554.42M | 2.63% | +$76.72M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 5,604,483 | 5,604,483 | 0 | $622.27M | $533.63M | 2.54% | -$88.63M |
| Praxis Precision Medicines, Inc.(PRAX) | 1,753,198 | 1,753,198 | 0 | $586.95M | $510.58M | 2.43% | -$76.37M |
| AbCellera Biologics Inc.(ABCL) | 33,012,138 | 33,012,139 | +1 | $259.15M | $481.65M | 2.29% | +$222.50M |
| Alkermes plcSHS(ALKS) | 10,012,267 | 10,012,267 | 0 | $524.59M | $405.70M | 1.93% | -$118.90M |
| Celcuity Inc.(CELC) | 7,915,792 | 4,815,792 | -3,100,000 | $828.15M | $382.95M | 1.82% | -$445.20M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 2,834,643 | 2,834,643 | 0 | $181.28M | $211.49M | 1.00% | +$30.22M |
| IDEAYA Biosciences, Inc.(IDYA) | 5,010,030 | 5,010,030 | 0 | $186.72M | $192.49M | 0.91% | +$5.76M |
| Edgewise Therapeutics, Inc.(EWTX) | 3,701,719 | 3,701,719 | 0 | $150.40M | $150.29M | 0.71% | -$111.1K |
| Replimune Group, Inc.(REPL) | 11,045,336 | 11,045,336 | 0 | $122.27M | $146.24M | 0.69% | +$23.97M |
| Roivant Sciences Ltd.SHS(ROIV) | 4,716,831 | 3,660,352 | -1,056,479 | $166.93M | $133.86M | 0.64% | -$33.07M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 1,992,783 | 1,709,053 | -283,730 | $162.43M | $111.86M | 0.53% | -$50.57M |
| Nurix Therapeutics, Inc.(NRIX) | 4,658,556 | 4,658,556 | 0 | $113.02M | $110.45M | 0.52% | -$2.56M |
| Immunovant, Inc.(IMVT) | 5,435,220 | 2,770,377 | -2,664,843 | $209.42M | $93.58M | 0.44% | -$115.84M |
| Celldex Therapeutics, Inc.(CLDX) | 1,182,611 | 2,564,984 | +1,382,373 | $44.00M | $83.13M | 0.40% | +$39.13M |
| Denali Therapeutics Inc.(DNLI) | 3,734,336 | 3,734,336 | 0 | $96.05M | $77.19M | 0.37% | -$18.86M |
| Dianthus Therapeutics, Inc.(DNTH) | 852,164 | 852,164 | 0 | $83.07M | $75.03M | 0.36% | -$8.04M |
| Celcuity Inc.NOTE 2 75 8 1 2031(CELC) | 0 | 0 | 0 | $69.16M | $55.46M | 0.26% | -$13.70M |
| Rapport Therapeutics, Inc.(RAPP) | 1,547,090 | 1,547,090 | 0 | $64.47M | $51.98M | 0.25% | -$12.49M |
| Monte Rosa Therapeutics, Inc. | 4,345,736 | 4,345,736 | 0 | $105.17M | $51.84M | 0.25% | -$53.32M |
| Relay Therapeutics, Inc.(RLAY) | 2,826,783 | 2,826,783 | 0 | $52.89M | $51.02M | 0.24% | -$1.87M |
| Ionis Pharmaceuticals, Inc.(IONS) | 2,047,727 | 1,023,864 | -1,023,863 | $162.36M | $45.72M | 0.22% | -$116.65M |
| Structure Therapeutics Inc.ADS | 1,432,529 | 1,432,529 | 0 | $76.88M | $44.80M | 0.21% | -$32.09M |
| Enliven Therapeutics, Inc. | 905,191 | 905,191 | 0 | $45.94M | $41.49M | 0.20% | -$4.44M |
| Bicycle Therapeutics plcADS | 10,885,357 | 10,885,357 | 0 | $46.15M | $40.06M | 0.19% | -$6.10M |
| Prelude Therapeutics Inc. | 10,123,824 | 10,123,824 | 0 | $53.96M | $39.58M | 0.19% | -$14.38M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 445,975 | 445,975 | 0 | $52.21M | $38.12M | 0.18% | -$14.09M |
| Design Therapeutics, Inc. | 2,678,430 | 2,988,144 | +309,714 | $38.76M | $37.56M | 0.18% | -$1.20M |
| Immatics N.V.SHS(IMTX) | 9,508,565 | 4,256,682 | -5,251,883 | $96.32M | $37.37M | 0.18% | -$58.95M |
| Stoke Therapeutics, Inc.(STOK) | 3,336,697 | 1,313,999 | -2,022,698 | $109.18M | $34.16M | 0.16% | -$75.01M |
| Entrada Therapeutics, Inc. | 5,072,730 | 5,072,730 | 0 | $37.34M | $32.21M | 0.15% | -$5.12M |
| Neurogene Inc. | 991,691 | 991,691 | 0 | $31.19M | $27.59M | 0.13% | -$3.60M |
| Xencor, Inc.(XNCR) | 1,102,106 | 1,102,106 | 0 | $17.74M | $27.50M | 0.13% | +$9.75M |
| Faeth Therapeutics, Inc. | 1,286,411 | 803,425 | -482,986 | $32.16M | $23.89M | 0.11% | -$8.27M |
| Absci Corporation | 2,134,803 | 2,134,803 | 0 | $24.74M | $22.99M | 0.11% | -$1.75M |
| Disc Medicine, Inc.(IRON) | 349,657 | 349,657 | 0 | $25.57M | $22.89M | 0.11% | -$2.69M |
| Arcus Biosciences, Inc.(RCUS) | 844,816 | 844,816 | 0 | $26.05M | $21.82M | 0.10% | -$4.22M |
| Generate Biomedicines, Inc.(GENB) | 1,423,602 | 1,423,602 | 0 | $24.02M | $21.38M | 0.10% | -$2.63M |
| Taysha Gene Therapies, Inc.(TSHA) | 4,004,756 | 4,004,756 | 0 | $27.27M | $19.50M | 0.09% | -$7.77M |
| Aktis Oncology, Inc.(AKTS) | 996,351 | 996,351 | 0 | $32.11M | $19.40M | 0.09% | -$12.71M |
| Jade Biosciences, Inc. | 1,230,426 | 1,230,426 | 0 | $27.34M | $17.29M | 0.08% | -$10.05M |
| DBV Technologies S.A.ADS | 1,461,425 | 1,461,425 | 0 | $23.97M | $17.19M | 0.08% | -$6.78M |
| First Tracks Biotherapeutics, Inc. | 0 | 472,932 | +472,932 | $0 | $16.76M | 0.08% | +$16.76M |
| Parabilis Medicines, Inc. | 500,000 | 500,000 | 0 | $13.69M | $16.14M | 0.08% | +$2.46M |
| Tectonic Therapeutic, Inc. | 607,788 | 607,788 | 0 | $20.89M | $14.16M | 0.07% | -$6.74M |
| Cytokinetics, Incorporated(CYTK) | 211,267 | 211,267 | 0 | $18.00M | $13.92M | 0.07% | -$4.07M |
| Xenon Pharmaceuticals Inc.(XENE) | 370,208 | 370,208 | 0 | $22.35M | $13.77M | 0.07% | -$8.58M |
| CytomX Therapeutics, Inc. | 4,975,826 | 4,975,826 | 0 | $18.66M | $13.53M | 0.06% | -$5.13M |
| Dyne Therapeutics, Inc.(DYN) | 813,449 | 813,449 | 0 | $18.07M | $13.10M | 0.06% | -$4.96M |
| Scribe Therapeutics Inc. | 0 | 688,691 | +688,691 | $0 | $12.68M | 0.06% | +$12.68M |
| Freenome, Inc. | 0 | 794,908 | +794,908 | $0 | $12.52M | 0.06% | +$12.52M |
| MapLight Therapeutics, Inc. | 364,705 | 1,166,763 | +802,058 | $13.07M | $11.89M | 0.06% | -$1.18M |
| BioNTech SEADS(BNTX) | 119,743 | 119,743 | 0 | $11.14M | $11.77M | 0.06% | +$628.7K |
| Sera Prognostics, Inc.CL A | 5,498,170 | 5,498,170 | 0 | $10.01M | $11.49M | 0.05% | +$1.48M |
| Evommune, Inc. | 847,390 | 1,234,794 | +387,404 | $11.26M | $10.20M | 0.05% | -$1.06M |
| Intellia Therapeutics, Inc.(NTLA) | 930,232 | 829,053 | -101,179 | $15.74M | $10.00M | 0.05% | -$5.74M |
| Avalyn Pharma Inc. | 350,000 | 350,000 | 0 | $11.52M | $9.97M | 0.05% | -$1.55M |
| Avalo Therapeutics, Inc. | 550,000 | 550,000 | 0 | $10.16M | $8.43M | 0.04% | -$1.73M |
| Tango Therapeutics, Inc.(TNGX) | 333,333 | 333,333 | 0 | $10.42M | $8.32M | 0.04% | -$2.10M |
| LB Pharmaceuticals Inc(LBRX) | 200,000 | 200,000 | 0 | $6.49M | $7.68M | 0.04% | +$1.19M |
| Protara Therapeutics, Inc. | 971,614 | 1,843,795 | +872,181 | $3.71M | $5.62M | 0.03% | +$1.91M |
| Cerus Corporation | 6,395,431 | 2,333,155 | -4,062,276 | $18.67M | $5.55M | 0.03% | -$13.12M |
| vTv Therapeutics, Inc.CL A | 148,314 | 148,314 | 0 | $5.58M | $4.57M | 0.02% | -$1.01M |
| Q32 Bio Inc. | 0 | 547,945 | +547,945 | $0 | $4.53M | 0.02% | +$4.53M |
| Eikon Therapeutics, Inc. | 555,555 | 555,555 | 0 | $7.25M | $4.47M | 0.02% | -$2.78M |
| Immunome, Inc.(IMNM) | 55,306 | 55,306 | 0 | $1.17M | $1.19M | 0.01% | +$17.7K |
| Sana Biotechnology, Inc. | 310,483 | 310,483 | 0 | $1.08M | $905.1K | 0.00% | -$178.5K |
| TScan Therapeutics, Inc. | 2,784,792 | 2,784,792 | 0 | $2.73M | $875.8K | 0.00% | -$1.85M |
| Aligos Therapeutics, Inc. | 83,055 | 83,055 | 0 | $479.2K | $467.6K | 0.00% | -$11.6K |
| Skye Bioscience, Inc. | 0 | 196,905 | +196,905 | $0 | $317.0K | 0.00% | +$317.0K |
| Tyra Biosciences, Inc.(TYRA) | 10,607 | 10,607 | 0 | $338.8K | $232.0K | 0.00% | -$106.8K |
| Alumis Inc. | 2,012,500 | 0 | -2,012,500 | $56.63M | $0 | — | -$56.63M |
| Crinetics Pharmaceuticals, Inc. | 2,351,465 | 0 | -2,351,465 | $87.99M | $0 | — | -$87.99M |
| Sagimet Biosciences Inc.COM SER A(SGMT) | 952,996 | 0 | -952,996 | $7.37M | $0 | — | -$7.37M |
| Sionna Therapeutics, Inc.(SION) | 400,000 | 0 | -400,000 | $17.60M | $0 | — | -$17.60M |
| Skye Bioscience, Inc.(SKYE) | 1,575,243 | 0 | -1,575,243 | $1.09M | $0 | — | -$1.09M |
| Surrozen, Inc.W EXP 8 11 2026(SRZN) | 833,333 | 0 | -833,333 | $13.8K | $0 | — | -$13.8K |
| Verastem, Inc.(VSTM) | 2,499,338 | 0 | -2,499,338 | $9.55M | $0 | — | -$9.55M |
| Viridian Therapeutics, Inc.(VRDN) | 2,383,025 | 0 | -2,383,025 | $43.78M | $0 | — | -$43.78M |
| Wave Life Sciences, Inc.SHS(WVE) | 822,638 | 0 | -822,638 | $4.78M | $0 | — | -$4.78M |